FOGC.F Stock Overview
Avisa Diagnostics Inc. operates a clinical-stage medical device company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Avisa Diagnostics Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.00001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| FOGC.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | 0.4% |
| 1Y | n/a | -0.6% | 22.9% |
Return vs Industry: Insufficient data to determine how FOGC.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how FOGC.F performed against the US Market.
Price Volatility
| FOGC.F volatility | |
|---|---|
| FOGC.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: FOGC.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine FOGC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | David Joseph | www.avisadx.com |
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and community-acquired pneumonia.
Avisa Diagnostics Inc. Fundamentals Summary
| FOGC.F fundamental statistics | |
|---|---|
| Market cap | US$59.00 |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs FOGC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FOGC.F income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did FOGC.F perform over the long term?
See historical performance and comparison